Biodesix earnings missed, revenue topped estimates
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biodesix Inc (BDSX)
Biodesix Inc stock price live, this page displays NASDAQ BDSX stock exchange data. View the BDSX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biodesix Inc real time stock price chart below.
What Is the Biodesix Inc Stock Price Today?
The Biodesix Inc stock price today is 0.397.
What Is the Stock Symbol for Biodesix Inc?
The stock symbol for Biodesix Inc is ""BDSX.""
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BDSX quote. (ISIN: US09075X1081)
What Is the Biodesix Inc Stock Price Today?
The Biodesix Inc stock price today is 0.397.
What Is the Stock Symbol for Biodesix Inc?
The stock symbol for Biodesix Inc is ""BDSX.""
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BDSX quote. (ISIN: US09075X1081)
NASDAQ
Currency in USD
0.397
+0.007(+1.85%)
Real-time Data·
Fair Value
An estimate of a Biodesix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.380
0.422
52 wk Range
0.172
2.040
BDSX Scorecard
Full Analysis
Operates with a significant debt burden
BDSX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Biodesix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3800.422
52 wk Range
0.1722.040
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BDSX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Biodesix's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1.750
Upside
+340.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Biodesix Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Biodesix earnings missed, revenue topped estimates
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Biodesix Inc Company Profile
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Biodesix Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue up 21% YoY to $18M, driven by 18% growth in lung diagnostic testing and 61% in development services
- Stock declined 16.49% post-earnings to $0.30, as 2025 revenue guidance revised down to $80-85M
- Net loss improved 18% YoY to $11.1M; company targets adjusted EBITDA positivity by Q4 2025
- Gross margin improved to 79.4%; company plans to expand primary care sales team and explore MRD test commercialization
- CEO emphasized focus on revenue growth, operational effectiveness, and pipeline advancement amid market challenges
Last Updated: 13/05/2025, 22:50
Read Full TranscriptCompare BDSX to Peers and Sector
Metrics to compare | BDSX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBDSXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −0.6x | −0.5x | |
PEG Ratio | −0.04 | 0.00 | 0.00 | |
Price/Book | 51.9x | 0.4x | 2.6x | |
Price / LTM Sales | 0.8x | 0.8x | 3.3x | |
Upside (Analyst Target) | 348.7% | 41.5% | 42.9% | |
Fair Value Upside | Unlock | 14.9% | 6.2% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1.750
(+340.81% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.08 / -0.07
Revenue / Forecast
20.00M / 18.49M
People Also Watch
FAQ
What Stock Exchange Does Biodesix Trade On?
Biodesix is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Biodesix?
The stock symbol for Biodesix is "BDSX."
What Is the Biodesix Market Cap?
As of today, Biodesix market cap is 59.53M.
What Is Biodesix's Earnings Per Share (TTM)?
The Biodesix EPS (TTM) is -0.28.
When Is the Next Biodesix Earnings Date?
Biodesix will release its next earnings report on 30 Oct 2025.
From a Technical Analysis Perspective, Is BDSX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Biodesix Stock Split?
Biodesix has split 0 times.
How Many Employees Does Biodesix Have?
Biodesix has 273 employees.
What is the current trading status of Biodesix (BDSX)?
As of 12 Aug 2025, Biodesix (BDSX) is trading at a price of 0.40, with a previous close of 0.39. The stock has fluctuated within a day range of 0.38 to 0.42, while its 52-week range spans from 0.17 to 2.04.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.